{"id":275354,"date":"2025-10-03T19:47:08","date_gmt":"2025-10-03T19:47:08","guid":{"rendered":"https:\/\/www.europesays.com\/us\/275354\/"},"modified":"2025-10-03T19:47:08","modified_gmt":"2025-10-03T19:47:08","slug":"university-of-houston-collaborates-with-texas-medical-center-institutions-to-train-next-generation-of-kidney-and-blood-disorder-researchers","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/275354\/","title":{"rendered":"University of Houston Collaborates with Texas Medical Center Institutions to Train Next Generation of Kidney and Blood Disorder Researchers"},"content":{"rendered":"<p>                           Key Takeaways<\/p>\n<ul>\n<li>UH joins the Texas Medical Center in launching an incubator for kidney, urologic and<br \/>\n                                 hematologic training to strengthen the workforce and prepare students for impactful<br \/>\n                                 careers.<\/li>\n<li>The collaboration leverages the University\u2019s strengths in biomedical and crystals<br \/>\n                                 research.\u00a0<\/li>\n<li>Houston has a significant burden of kidney diseases, hypertension, sickle cell disease<br \/>\n                                 and other nonmalignant hematologic conditions.<\/li>\n<\/ul>\n<p>Leveraging the University of Houston\u2019s strengths in biomedical research and education,<br \/>\n                              the Texas Medical Center, with its world-class hospitals, clinical and research programs,<br \/>\n                              is partnering with UH to expand opportunities for training, discovery and innovations<br \/>\n                              in health. The group, led by Baylor College of Medicine, is working to strengthen<br \/>\n                              the pipeline for future kidney, urologic and hematologic research.\u00a0<br \/>\u00a0\u00a0<br \/>Researchers will receive $6.25 million over five years from the National Institutes<br \/>\n                              of Health to launch the Houston Area Incubator for Kidney, Urologic and Hematologic<br \/>\n                              Research Training.\u00a0<br \/>\u00a0\u00a0<br \/>At UH, the program director is Jeffrey Rimer, Abraham E. Dukler Endowed Professor<br \/>\n                              of Chemical Engineering, who is known globally for his seminal breakthroughs using<br \/>\n                              innovative methods to control crystals to help treat malaria and kidney stones. \u00a0<\/p>\n<blockquote>\n<p>\u201cWe currently have an NIH R01 grant with UT Southwestern Medical School where we are<br \/>\n                                 developing next-generation drugs to treat calcium-based kidney stones,\u201d said Rimer.<br \/>\n                                 \u201cThis new NIH-sponsored training program will enable us to recruit talented students<br \/>\n                                 and postdocs to work on these challenging areas of research.\u201d<\/p>\n<\/blockquote>\n<p>Houston has a significant burden of kidney diseases, hypertension, sickle cell disease<br \/>\n                                 and other nonmalignant hematologic conditions. HAI-KUH\u2019s mission is to improve the<br \/>\n                                 health of these patients by building a strong scientific workforce to address their<br \/>\n                                 needs. HAI-KUH will leverage the team&#8217;s biomedical research resources to develop research<br \/>\n                                 skills of students and trainees and prepare them for sustained and impactful careers<br \/>\n                                 in KUH research professions.\u00a0 <\/p>\n<p>The program will fund six predoctoral students and six postdoctoral associates selected<br \/>\n                                 through a competitive application process. Trainees will receive support in scientific<br \/>\n                                 research, professional development and networking.\u00a0<\/p>\n<p>HAI-KUH includes 58 investigators from Baylor College of Medicine, Texas Children\u2019s<br \/>\n                              Hospital, University of Texas Health Science Center at Houston, the University of<br \/>\n                              Houston, Houston Methodist Research Institute, University of Texas MD Anderson Cancer<br \/>\n                              Center, Rice University and Texas A&amp;M University Institute of Biosciences and Technology.<\/p>\n<p>The multidisciplinary team is engaged in a breadth of KUH disease, addressing development,<br \/>\n                              prevention, diagnostics and treatment. HAI-KUH will provide trainees with the opportunity<br \/>\n                              to collaborate across institutions and fields of study.\u00a0<br \/>\u00a0\u00a0<br \/>The projects principal investigators are Dr. Alison Bertuch, professor of pediatrics<br \/>\n                              \u2013 oncology and molecular and human genetics at Baylor and Texas Children\u2019s, Peter<br \/>\n                              Doris, professor and director of the Institute of Molecular Medicine Center for Human<br \/>\n                              Genetics at UT Health, and Margaret Goodell, professor and chair of the Department<br \/>\n                              of Molecular and Cellular Biology at Baylor. Core leads are Dr. Chester Koh (Baylor\/Texas<br \/>\n                              Children\u2019s), Rachel Miller (UT Health) and Dr. Rayne Rouce (Baylor\/Texas Children\u2019s).<br \/>\n                              \u00a0<br \/>\u00a0\u00a0<br \/>Along with Rimer, co-investigators are Dr. Wolfgang Winkelmeyer (Baylor), Oleh Pochynyuk<br \/>\n                              (UTHealth), Dr. Rose Khavari (Houston Methodist) and Pamela Wenzel (UT Health). \u00a0<br \/>\u00a0\u00a0<br \/>This work is funded by the National Institute of Diabetes and Digestive and Kidney<br \/>\n                              Diseases (U2CDK143942 and TL1DK147564).\u00a0<br \/>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Key Takeaways UH joins the Texas Medical Center in launching an incubator for kidney, urologic and hematologic training&hellip;\n","protected":false},"author":3,"featured_media":275355,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5130],"tags":[4345,358,3187],"class_list":{"0":"post-275354","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-houston","8":"tag-houston","9":"tag-texas","10":"tag-tx"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115311964612937023","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/275354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=275354"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/275354\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/275355"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=275354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=275354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=275354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}